Allos Therapeutics Stock Price, News & Analysis (NASDAQ:ALTH)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Allos Therapeutics (NASDAQ:ALTH)

Allos Therapeutics logoAllos Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of anti-cancer therapeutics. As of December 31, 2011, the Company focused on the development and commercialization of FOLOTYN (pralatrexate injection). FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. FOLOTYN targets the inhibition of dihydrofolate reductase (DHFR), an enzyme critical in the folate pathway, thereby interfering with deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis and triggering cancer cell death. FOLOTYN can be delivered as a single agent, for which the Company has approval for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), and can be used in combination therapy regimens. On September 5, 2012, Spectrum Pharmaceuticals, Inc. acquired Allos Therapeutics, Inc.

Receive ALTH News and Ratings via Email

Sign-up to receive the latest news and ratings for ALTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:ALTH
CUSIPN/A
Phone+1-303-4266262

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Allos Therapeutics (NASDAQ:ALTH) Frequently Asked Questions

What is Allos Therapeutics' stock symbol?

Allos Therapeutics trades on the NASDAQ under the ticker symbol "ALTH."

Who are some of Allos Therapeutics' key competitors?

How do I buy Allos Therapeutics stock?

Shares of Allos Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Allos Therapeutics?

Allos Therapeutics' mailing address is 11080 Circle Point Rd Ste 200, WESTMINSTER, CO 80020-2778, United States. The biopharmaceutical company can be reached via phone at +1-303-4266262.


MarketBeat Community Rating for Allos Therapeutics (ALTH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Allos Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allos Therapeutics (NASDAQ:ALTH) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Allos Therapeutics (NASDAQ:ALTH) Earnings History and Estimates Chart

Earnings by Quarter for Allos Therapeutics (NASDAQ:ALTH)

Allos Therapeutics (NASDAQ ALTH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2012($0.09)($0.01)ViewN/AView Earnings Details
11/3/2011($0.16)($0.11)ViewN/AView Earnings Details
8/4/2011($0.14)$0.02ViewN/AView Earnings Details
5/10/2011($0.15)($0.14)ViewN/AView Earnings Details
3/3/2011($0.18)($0.17)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Allos Therapeutics (NASDAQ:ALTH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Allos Therapeutics (NASDAQ:ALTH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Allos Therapeutics (NASDAQ ALTH)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Allos Therapeutics (NASDAQ ALTH) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Allos Therapeutics (NASDAQ:ALTH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Allos Therapeutics (NASDAQ:ALTH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allos Therapeutics (NASDAQ ALTH) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.